The latest news:

• Treatment Options For Malignant Gliomas. - Ben William's annual update!         Ben is an old friend and has been researching brain tumor treatments since he was diagnosed with a GBM almost 18 years ago.  He wrote one of the best books on the subject, Surviving Terminal Cancer.  Half of the book is his thoughts on how to manage having a "terminal" illness and the other half is about treatment options.  He updates the treatment options every year and allows us to post it on our website for free..  here is the annual update, and it includes the new standard of care for GBMs!
  



• Correlation between contrast enhancement on intraoperative magnetic resonance imaging and histopathology in glioblastoma.         This article says that a gbm is not limited to the area of contrast enhancement.  I have been saying over and over that we need things like Gliagen - the dye that lets a surgeon see where the tumor is during the operation.  This article backs up the need.
  



• Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-?B and HSP27/p38/AKT Pathways and by Inhibiting ABCB1.         I love this type of project. They are trying to find why the tumor becomes resistent to treatment and how to prevent that resistence.  They are using approved drugs - so if this can be shown to work in people, it can be used immediately by anyone and make a big impact.  
  



• Corticorelin Acetate Has Steroid-Sparing Effect in Brain Cancer         This may eventually be used instead of Decadron for  brain swelling.. without the bad side effects of steroids.  The trial only showed a small improvement but may be worth trying to avoid those side effects
  



• Pituitary Tumors – The Best Kept Secret In Medicine         Overview of pituitary tumors